A Study of Trimetrexate Plus Leucovorin in Children With Pneumocystis Carinii Pneumonia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of trimetrexate glucuronate with leucovorin protection in
pediatric patients with Pneumocystis carinii pneumonia (PCP) who are refractory to or have
demonstrated severe or life-threatening toxicities to standard therapies (e.g., TMP/SMX or
parenteral pentamidine).